152 related articles for article (PubMed ID: 12637537)
1. Bone morphogenetic protein-1 (BMP-1). Identification of the minimal domain structure for procollagen C-proteinase activity.
Hartigan N; Garrigue-Antar L; Kadler KE
J Biol Chem; 2003 May; 278(20):18045-9. PubMed ID: 12637537
[TBL] [Abstract][Full Text] [Related]
2. Identification of the minimal domain structure of bone morphogenetic protein-1 (BMP-1) for chordinase activity: chordinase activity is not enhanced by procollagen C-proteinase enhancer-1 (PCPE-1).
Petropoulou V; Garrigue-Antar L; Kadler KE
J Biol Chem; 2005 Jun; 280(24):22616-23. PubMed ID: 15817489
[TBL] [Abstract][Full Text] [Related]
3. The interaction of recombinant subdomains of the procollagen C-proteinase with procollagen I provides a quantitative explanation for functional differences between the two splice variants, mammalian tolloid and bone morphogenetic protein 1.
Hintze V; Höwel M; Wermter C; Grosse Berkhoff E; Becker-Pauly C; Beermann B; Yiallouros I; Stöcker W
Biochemistry; 2006 May; 45(21):6741-8. PubMed ID: 16716085
[TBL] [Abstract][Full Text] [Related]
4. Structure and function of procollagen C-proteinase (mTolloid) domains determined by protease digestion, circular dichroism, binding to procollagen type I, and computer modeling.
Sieron AL; Tretiakova A; Jameson BA; Segall ML; Lund-Katz S; Khan MT; Li Sw; Stöcker W
Biochemistry; 2000 Mar; 39(12):3231-9. PubMed ID: 10727214
[TBL] [Abstract][Full Text] [Related]
5. Deletion of epidermal growth factor-like domains converts mammalian tolloid into a chordinase and effective procollagen C-proteinase.
Garrigue-Antar L; François V; Kadler KE
J Biol Chem; 2004 Nov; 279(48):49835-41. PubMed ID: 15381708
[TBL] [Abstract][Full Text] [Related]
6. Mammalian tolloid-like 1 binds procollagen C-proteinase enhancer protein 1 and differs from bone morphogenetic protein 1 in the functional roles of homologous protein domains.
Ge G; Zhang Y; Steiglitz BM; Greenspan DS
J Biol Chem; 2006 Apr; 281(16):10786-98. PubMed ID: 16507574
[TBL] [Abstract][Full Text] [Related]
7. Post-translational modification of bone morphogenetic protein-1 is required for secretion and stability of the protein.
Garrigue-Antar L; Hartigan N; Kadler KE
J Biol Chem; 2002 Nov; 277(45):43327-34. PubMed ID: 12218058
[TBL] [Abstract][Full Text] [Related]
8. Insights into how CUB domains can exert specific functions while sharing a common fold: conserved and specific features of the CUB1 domain contribute to the molecular basis of procollagen C-proteinase enhancer-1 activity.
Blanc G; Font B; Eichenberger D; Moreau C; Ricard-Blum S; Hulmes DJ; Moali C
J Biol Chem; 2007 Jun; 282(23):16924-33. PubMed ID: 17446170
[TBL] [Abstract][Full Text] [Related]
9. Identification of amino acid residues in bone morphogenetic protein-1 important for procollagen C-proteinase activity.
Garrigue-Antar L; Barker C; Kadler KE
J Biol Chem; 2001 Jul; 276(28):26237-42. PubMed ID: 11283002
[TBL] [Abstract][Full Text] [Related]
10. The protease domain of procollagen C-proteinase (BMP1) lacks substrate selectivity, which is conferred by non-proteolytic domains.
Wermter C; Höwel M; Hintze V; Bombosch B; Aufenvenne K; Yiallouros I; Stöcker W
Biol Chem; 2007 May; 388(5):513-21. PubMed ID: 17516847
[TBL] [Abstract][Full Text] [Related]
11. Strong cooperativity and loose geometry between CUB domains are the basis for procollagen c-proteinase enhancer activity.
Kronenberg D; Vadon-Le Goff S; Bourhis JM; Font B; Eichenberger D; Hulmes DJ; Moali C
J Biol Chem; 2009 Nov; 284(48):33437-46. PubMed ID: 19801683
[TBL] [Abstract][Full Text] [Related]
12. Paired basic/Furin-like proprotein convertase cleavage of Pro-BMP-1 in the trans-Golgi network.
Leighton M; Kadler KE
J Biol Chem; 2003 May; 278(20):18478-84. PubMed ID: 12637569
[TBL] [Abstract][Full Text] [Related]
13. Use of Bmp1/Tll1 doubly homozygous null mice and proteomics to identify and validate in vivo substrates of bone morphogenetic protein 1/tolloid-like metalloproteinases.
Pappano WN; Steiglitz BM; Scott IC; Keene DR; Greenspan DS
Mol Cell Biol; 2003 Jul; 23(13):4428-38. PubMed ID: 12808086
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a novel gene product (mammalian tolloid-like) with high sequence similarity to mammalian tolloid/bone morphogenetic protein-1.
Takahara K; Brevard R; Hoffman GG; Suzuki N; Greenspan DS
Genomics; 1996 Jun; 34(2):157-65. PubMed ID: 8661043
[TBL] [Abstract][Full Text] [Related]
15. The CUB domains of procollagen C-proteinase enhancer control collagen assembly solely by their effect on procollagen C-proteinase/bone morphogenetic protein-1.
Hulmes DJ; Mould AP; Kessler E
Matrix Biol; 1997 Apr; 16(1):41-5. PubMed ID: 9181553
[TBL] [Abstract][Full Text] [Related]
16. Multiple bone morphogenetic protein 1-related mammalian metalloproteinases process pro-lysyl oxidase at the correct physiological site and control lysyl oxidase activation in mouse embryo fibroblast cultures.
Uzel MI; Scott IC; Babakhanlou-Chase H; Palamakumbura AH; Pappano WN; Hong HH; Greenspan DS; Trackman PC
J Biol Chem; 2001 Jun; 276(25):22537-43. PubMed ID: 11313359
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta regulation of bone morphogenetic protein-1/procollagen C-proteinase and related proteins in fibrogenic cells and keratinocytes.
Lee S; Solow-Cordero DE; Kessler E; Takahara K; Greenspan DS
J Biol Chem; 1997 Jul; 272(30):19059-66. PubMed ID: 9228090
[TBL] [Abstract][Full Text] [Related]
18. Procollagen C-proteinase enhancer-1 (PCPE-1) interacts with beta2-microglobulin (beta2-m) and may help initiate beta2-m amyloid fibril formation in connective tissues.
Morimoto H; Wada J; Font B; Mott JD; Hulmes DJ; Ookoshi T; Naiki H; Yasuhara A; Nakatsuka A; Fukuoka K; Takatori Y; Ichikawa H; Akagi S; Nakao K; Makino H
Matrix Biol; 2008 Apr; 27(3):211-9. PubMed ID: 18164932
[TBL] [Abstract][Full Text] [Related]
19. Folding and activity of recombinant human procollagen C-proteinase enhancer.
Moschcovich L; Bernocco S; Font B; Rivkin H; Eichenberger D; Chejanovsky N; Hulmes DJ; Kessler E
Eur J Biochem; 2001 May; 268(10):2991-6. PubMed ID: 11358517
[TBL] [Abstract][Full Text] [Related]
20. Altered proteolytic activities of ADAMTS-4 expressed by C-terminal processing.
Kashiwagi M; Enghild JJ; Gendron C; Hughes C; Caterson B; Itoh Y; Nagase H
J Biol Chem; 2004 Mar; 279(11):10109-19. PubMed ID: 14662755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
